Sort
48,018 grants matching “immunotherapy”
Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy
$369,546Trisha M Wise-Draper · University Of Cincinnati · U01 · FY2025 · CA
Monoclonal Antibodies for the Study of P. carinii
$369,544Francis Gigliotti · University Of Rochester · R01 · FY2007 · AI
APOBEC3 Proteins in HIV Restriction
$369,525Reuben S Harris · University Of Texas Hlth Science Center · R37 · FY2022 · AI
MECHANISMS OF NONSTERILIZING IMMUNITY IN MALARIA
$369,517University Of Wisconsin Madison · R01 · FY2000 · AI
Hodgkin's Lymphoma Stem Cells
$369,477Richard Ambinder · Johns Hopkins University · P01 · FY2010 · CA
Regulation of memory CD8 T cell development
$369,454Susan M Kaech · Yale University · R01 · FY2009 · AI
Imaging tumor associated macrophage (TAM) function
$369,444Ralph Weissleder · Massachusetts General Hospital · R01 · FY2019 · CA
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
$369,431Hideho Okada · University Of California, San Francisco · R01 · FY2020 · CA
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
$369,431Hideho Okada · University Of California, San Francisco · R01 · FY2021 · CA
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
$369,431Youli Zu · Methodist Hospital Research Institute · R01 · FY2021 · CA
The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker
$369,431Bin He · Methodist Hospital Research Institute · R01 · FY2021 · CA
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
$369,431Youli Zu · Methodist Hospital Research Institute · R01 · FY2018 · CA
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
$369,431Youli Zu · Methodist Hospital Research Institute · R01 · FY2020 · CA
A novel T-cell subset able to kill relapsed cancers
$369,431Qing Yi · Methodist Hospital Research Institute · R01 · FY2020 · CA
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
$369,404Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
$369,404Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
$369,383Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Core 2: Tissue Imaging and Profiling Core
$369,373Rong Fan · Institute For Systems Biology · U54 · FY2022 · CA
Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy
$369,354Elad Ziv · University Of California, San Francisco · P20 · FY2024 · CA
X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research
$369,348Ken Kang-Hsin Wang · Ut Southwestern Medical Center · R37 · FY2022 · CA
Inferring Kinase Activity from Tumor Phosphoproteomic Data
$369,343Kristen M Naegle · University Of Virginia · U01 · FY2024 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$369,337Tracy L McGaha · University Health Network · R01 · FY2022 · CA
beta-Amyloid Antibodies w/ Specific Proteolytic Activity
$369,275University Of Texas Hlth Sci Ctr Houston · R01 · FY2005 · AG
CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER
$369,259Case Western Reserve University · R01 · FY2001 · CA
Resource for Nonhuman Primate Immune Reagents
$369,250Francois J Villinger · Emory University · R24 · FY2006 · RR